Moderna's coronavirus vaccine found to be nearly 95 percent effective in a preliminary analysis Moderna's coronavirus vaccine found to be nearly 95 percent effective in a preliminary analysis
MONDAY, NOVEMBER 16, 2020
Biotechnology firm Moderna announced Monday that a preliminary analysis shows its experimental coronavirus vaccine is nearly 95 percent effective at preventing illness, including severe cases - a striking initial result that leaves the United States with the prospect that two coronavirus vaccines could be available on a limited basis by the end of the year.